Phase 1b, Open-Label, Exploratory Biomarker Basket Study of S-4321 in Participants With an Autoimmune or Immune-Mediated Disease
Latest Information Update: 11 Mar 2026
At a glance
- Drugs S-4321 (Primary)
- Indications Atopic dermatitis; Cutaneous lupus erythematosus; Plaque psoriasis; Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Biomarker
- Sponsors Seismic Bio
Most Recent Events
- 11 Mar 2026 New trial record